Incretin-Based Therapies: A Promising Approach for Modulating Oxidative Stress and Insulin Resistance in Sarcopenia.
基於胰高血糖素的療法:調節肌少症中的氧化壓力和胰島素抵抗的有前景方法。
J Bone Metab 2024-11-04
Type 2 Diabetes Mellitus and Sarcopenia as Comorbid Chronic Diseases in Older Adults: Established and Emerging Treatments and Therapies.
老年人中的2型糖尿病和肌少症作為共病慢性疾病:已確立和新興的治療和療法。
Diabetes Metab J 2024-03-19
Pathophysiological interactions between sarcopenia and type 2 diabetes: A two-way street influencing diagnosis and therapeutic options.
肌少症與2型糖尿病之間的病理生理相互作用:影響診斷和治療選項的雙向關係。
Diabetes Obes Metab 2024-01-09
Worldwide burden of antidiabetic drug-induced sarcopenia: An international pharmacovigilance study.
全球抗糖尿病藥物引起的肌肉減少症負擔:一項國際藥物監測研究。
Arch Gerontol Geriatr 2024-10-24
The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation.
體重減輕對無脂肪質量、肌肉、骨骼和造血健康的影響:對新興藥物療法在脂肪減少和保護瘦體重方面的啟示。
Metabolism 2024-10-31